Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 143

1.

The impact of diabetes mellitus on the clinical phenotype of hypertrophic cardiomyopathy.

Wasserstrum Y, Barriales-Villa R, Fernández-Fernández X, Adler Y, Lotan D, Peled Y, Klempfner R, Kuperstein R, Shlomo N, Sabbag A, Freimark D, Monserrat L, Arad M.

Eur Heart J. 2018 Oct 25. doi: 10.1093/eurheartj/ehy625. [Epub ahead of print]

PMID:
30358878
2.

Structured, Protocol-Based Pulse-Oximetry Measurement Improves the Evaluation of Hypoxemic Patients at Hospital Admission.

Carmel-Neiderman NN, Goren I, Wasserstrum Y, Frenkel Rutenberg T, Barbarova I, Rapoport A, Lotan D, Ramaty E, Peltz-Sinvani N, Brom A, Kogan M, Panina Y, Rosman M, Friedrich C, Gringauz I, Dagan A, Kliers I, Ziv-Baran T, Segal G.

Isr Med Assoc J. 2018 Mar;20(3):147-150.

3.

Severe fetal hydronephrosis: the added value of associated congenital anomalies of the kidneys and urinary tract (CAKUT) in the prediction of postnatal outcome.

Perlman S, Roitman L, Lotan D, Kivilevitch Z, Pode-Shakked N, Pode-Shakked B, Achiron R, Dekel B, Gilboa Y.

Prenat Diagn. 2018 Feb;38(3):179-183. doi: 10.1002/pd.5206. Epub 2018 Feb 7.

PMID:
29314159
4.

Crossed ectopic kidney: prenatal diagnosis and postnatal follow-up.

Zajicek M, Perlman S, Dekel B, Lahav E, Lotan D, Lotan D, Achiron R, Gilboa Y.

Prenat Diagn. 2017 Jul;37(7):712-715. doi: 10.1002/pd.5070. Epub 2017 Jun 13.

PMID:
28505705
5.

The role of direct single monetary grants in residents' choice of field of residency.

Wasserstrum Y, Magnezi R, Tamir O, Koren S, Lotan D, Afek A.

Med Teach. 2017 May;39(5):548-554. doi: 10.1080/0142159X.2017.1297891. Epub 2017 Mar 10.

PMID:
28281835
6.

The effect of subclinical infantile thiamine deficiency on motor function in preschool children.

Harel Y, Zuk L, Guindy M, Nakar O, Lotan D, Fattal-Valevski A.

Matern Child Nutr. 2017 Oct;13(4). doi: 10.1111/mcn.12397. Epub 2017 Jan 29.

PMID:
28133900
7.

Reckless administration of QT interval-prolonging agents in elderly patients with drug-induced torsade de pointes.

Jackobson G, Carmel NN, Lotan D, Kremer A, Justo D.

Z Gerontol Geriatr. 2018 Jan;51(1):41-47. doi: 10.1007/s00391-016-1155-5. Epub 2016 Nov 22.

PMID:
27878411
8.

Prenatal compensatory renal growth in unilateral renal agenesis.

Perlman S, Lotan D, Dekel B, Kivilevitch Z, Hazan Y, Achiron R, Gilboa Y.

Prenat Diagn. 2016 Nov;36(11):1075-1080. doi: 10.1002/pd.4938.

PMID:
27734512
9.

Corrected QT interval anomalies are associated with worse prognosis among patients suffering from sepsis.

Wasserstrum Y, Lotan D, Itelman E, Barbarova I, Kogan M, Klempfner R, Dagan A, Segal G.

Intern Med J. 2016 Oct;46(10):1204-1211. doi: 10.1111/imj.13170.

PMID:
27389311
10.

Usefulness of Novel Immunotherapeutic Strategies for Idiopathic Recurrent Pericarditis.

Lotan D, Wasserstrum Y, Fardman A, Kogan M, Adler Y.

Am J Cardiol. 2016 Mar 1;117(5):861-6. doi: 10.1016/j.amjcard.2015.12.012. Epub 2015 Dec 13. Review.

PMID:
26742476
11.

Antibiotic treatment attenuates behavioral and neurochemical changes induced by exposure of rats to group a streptococcal antigen.

Lotan D, Cunningham M, Joel D.

PLoS One. 2014 Jun 30;9(6):e101257. doi: 10.1371/journal.pone.0101257. eCollection 2014.

12.

Blood pressure in obese and overweight children and adolescents.

Mazor-Aronovitch K, Lotan D, Modan-Moses D, Fradkin A, Pinhas-Hamiel O.

Isr Med Assoc J. 2014 Mar;16(3):157-61.

13.

Glutaric Aciduria type I and acute renal failure - Coincidence or causality?

Pode-Shakked B, Marek-Yagel D, Rubinshtein M, Pessach IM, Paret G, Volkov A, Anikster Y, Lotan D.

Mol Genet Metab Rep. 2014 Apr 17;1:170-175. eCollection 2014.

14.

Escitalopram or novel herbal mixture treatments during or following exposure to stress reduce anxiety-like behavior through corticosterone and BDNF modifications.

Doron R, Lotan D, Versano Z, Benatav L, Franko M, Armoza S, Kately N, Rehavi M.

PLoS One. 2014 Apr 1;9(4):e91455. doi: 10.1371/journal.pone.0091455. eCollection 2014.

15.

A human integrin-α3 mutation confers major renal developmental defects.

Shukrun R, Vivante A, Pleniceanu O, Vax E, Anikster Y, Dekel B, Lotan D.

PLoS One. 2014 Mar 12;9(3):e90879. doi: 10.1371/journal.pone.0090879. eCollection 2014.

16.

Behavioral and neural effects of intra-striatal infusion of anti-streptococcal antibodies in rats.

Lotan D, Benhar I, Alvarez K, Mascaro-Blanco A, Brimberg L, Frenkel D, Cunningham MW, Joel D.

Brain Behav Immun. 2014 May;38:249-62. doi: 10.1016/j.bbi.2014.02.009. Epub 2014 Feb 20.

17.

Attention bias modification treatment augmenting effects on cognitive behavioral therapy in children with anxiety: randomized controlled trial.

Shechner T, Rimon-Chakir A, Britton JC, Lotan D, Apter A, Bliese PD, Pine DS, Bar-Haim Y.

J Am Acad Child Adolesc Psychiatry. 2014 Jan;53(1):61-71. doi: 10.1016/j.jaac.2013.09.016. Epub 2013 Oct 10.

18.

A novel herbal treatment reduces depressive-like behaviors and increases BDNF levels in the brain of stressed mice.

Doron R, Lotan D, Einat N, Yaffe R, Winer A, Marom I, Meron G, Kately N, Rehavi M.

Life Sci. 2014 Jan 17;94(2):151-7. doi: 10.1016/j.lfs.2013.10.025. Epub 2013 Nov 1.

PMID:
24184295
19.

Renal hypodysplasia associates with a WNT4 variant that causes aberrant canonical WNT signaling.

Vivante A, Mark-Danieli M, Davidovits M, Harari-Steinberg O, Omer D, Gnatek Y, Cleper R, Landau D, Kovalski Y, Weissman I, Eisenstein I, Soudack M, Wolf HR, Issler N, Lotan D, Anikster Y, Dekel B.

J Am Soc Nephrol. 2013 Mar;24(4):550-8. doi: 10.1681/ASN.2012010097. Epub 2013 Mar 21.

20.

Anxiolytic effects of a novel herbal treatment in mice models of anxiety.

Doron R, Lotan D, Rak-Rabl A, Raskin-Ramot A, Lavi K, Rehavi M.

Life Sci. 2012 Jun 27;90(25-26):995-1000. doi: 10.1016/j.lfs.2012.05.014. Epub 2012 Jun 5.

PMID:
22683433
21.

Behavioral, pharmacological, and immunological abnormalities after streptococcal exposure: a novel rat model of Sydenham chorea and related neuropsychiatric disorders.

Brimberg L, Benhar I, Mascaro-Blanco A, Alvarez K, Lotan D, Winter C, Klein J, Moses AE, Somnier FE, Leckman JF, Swedo SE, Cunningham MW, Joel D.

Neuropsychopharmacology. 2012 Aug;37(9):2076-87. doi: 10.1038/npp.2012.56. Epub 2012 Apr 25.

22.

Attention bias modification treatment for pediatric anxiety disorders: a randomized controlled trial.

Eldar S, Apter A, Lotan D, Edgar KP, Naim R, Fox NA, Pine DS, Bar-Haim Y.

Am J Psychiatry. 2012 Feb;169(2):213-20.

23.

Familial autosomal recessive renal tubular acidosis: importance of early diagnosis.

Vivante A, Lotan D, Pode-Shakked N, Landau D, Svec P, Nampoothiri S, Verma I, Abu-Libdeh A, Bockenhauer D, Dekel B, Anikster Y.

Nephron Physiol. 2011;119(3):p31-9. doi: 10.1159/000329668. Epub 2011 Aug 18.

PMID:
21849803
24.

The yield of early postnatal ultrasound scan in neonates with documented antenatal hydronephrosis.

Maayan-Metzger A, Lotan D, Jacobson JM, Raviv-Zilka L, Ben-Shlush A, Kuint J, Mor Y.

Am J Perinatol. 2011 Sep;28(8):613-8. doi: 10.1055/s-0031-1276735. Epub 2011 Apr 14.

PMID:
21494995
25.

Gprc5a deletion enhances the transformed phenotype in normal and malignant lung epithelial cells by eliciting persistent Stat3 signaling induced by autocrine leukemia inhibitory factor.

Chen Y, Deng J, Fujimoto J, Kadara H, Men T, Lotan D, Lotan R.

Cancer Res. 2010 Nov 1;70(21):8917-26. doi: 10.1158/0008-5472.CAN-10-0518. Epub 2010 Oct 19.

26.

Comparative functional genomics analysis of NNK tobacco-carcinogen induced lung adenocarcinoma development in Gprc5a-knockout mice.

Fujimoto J, Kadara H, Men T, van Pelt C, Lotan D, Lotan R.

PLoS One. 2010 Jul 29;5(7):e11847. doi: 10.1371/journal.pone.0011847.

27.
28.

Leptin and the post-operative inflammatory response. More insights into the correlation with the clinical course and glucocorticoid administration.

Modan-Moses D, Kanety H, Dagan O, Ehrlich S, Lotan D, Pariente C, Novikov I, Paret G.

J Endocrinol Invest. 2010 Nov;33(10):701-6. doi: 10.3275/6971. Epub 2010 Apr 12.

PMID:
20386086
29.

Knockout of the tumor suppressor gene Gprc5a in mice leads to NF-kappaB activation in airway epithelium and promotes lung inflammation and tumorigenesis.

Deng J, Fujimoto J, Ye XF, Men TY, Van Pelt CS, Chen YL, Lin XF, Kadara H, Tao Q, Lotan D, Lotan R.

Cancer Prev Res (Phila). 2010 Apr;3(4):424-37. doi: 10.1158/1940-6207.CAPR-10-0032. Epub 2010 Mar 30.

30.

Differential inhibition of protein translation machinery by curcumin in normal, immortalized, and malignant oral epithelial cells.

Chakravarti N, Kadara H, Yoon DJ, Shay JW, Myers JN, Lotan D, Sonenberg N, Lotan R.

Cancer Prev Res (Phila). 2010 Mar;3(3):331-8. doi: 10.1158/1940-6207.CAPR-09-0076. Epub 2010 Feb 9.

31.

Identification of gene signatures and molecular markers for human lung cancer prognosis using an in vitro lung carcinogenesis system.

Kadara H, Lacroix L, Behrens C, Solis L, Gu X, Lee JJ, Tahara E, Lotan D, Hong WK, Wistuba II, Lotan R.

Cancer Prev Res (Phila). 2009 Aug;2(8):702-11. doi: 10.1158/1940-6207.CAPR-09-0084. Epub 2009 Jul 28.

32.

Truncating mutations in the chloride/proton ClC-5 antiporter gene in Seven Jewish Israeli families with Dent's 1 disease.

Dinour D, Davidovitz M, Levin-Iaina N, Lotan D, Cleper R, Weissman I, Knecht A, Holtzman EJ.

Nephron Clin Pract. 2009;112(4):c262-7. doi: 10.1159/000224793. Epub 2009 Jun 16.

PMID:
19546586
33.

Activation of protein kinase C by phorbol 12-myristate 13-acetate suppresses the growth of lung cancer cells through KLF6 induction.

Tahara E, Kadara H, Lacroix L, Lotan D, Lotan R.

Cancer Biol Ther. 2009 May;8(9):801-7. Epub 2009 May 17.

PMID:
19333010
34.

Involvement of Rac in fenretinide-induced apoptosis.

Kadara H, Tahara E, Kim HJ, Lotan D, Myers J, Lotan R.

Cancer Res. 2008 Jun 1;68(11):4416-23. doi: 10.1158/0008-5472.CAN-08-0031.

35.

Mutations in the familial Mediterranean fever gene of patients with IgA nephropathy and other forms of glomerulonephritis.

Kukuy OL, Kopolovic J, Blau A, Ben-David A, Lotan D, Shaked M, Shinar Y, Dinour D, Langevitz P, Livneh A.

Clin Genet. 2008 Feb;73(2):146-51. doi: 10.1111/j.1399-0004.2007.00945.x. Epub 2007 Dec 19.

PMID:
18177471
36.

Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor gene.

Tao Q, Fujimoto J, Men T, Ye X, Deng J, Lacroix L, Clifford JL, Mao L, Van Pelt CS, Lee JJ, Lotan D, Lotan R.

J Natl Cancer Inst. 2007 Nov 21;99(22):1668-82. Epub 2007 Nov 13.

PMID:
18000218
37.

Expression of SDF-1/CXCR4 in injured human kidneys.

Lotan D, Sheinberg N, Kopolovic J, Dekel B.

Pediatr Nephrol. 2008 Jan;23(1):71-7. Epub 2007 Oct 31.

PMID:
17972109
38.

A combined approach to the molecular analysis of cystinuria: from urinalysis to sequencing via genotyping.

Lotan D, Yoskovitz G, Bisceglia L, Gerad L, Reznik-Wolf H, Pras E.

Isr Med Assoc J. 2007 Jul;9(7):513-6.

39.

Audiometric and imaging characteristics of distal renal tubular acidosis and deafness.

Joshua B, Kaplan DM, Raveh E, Lotan D, Anikster Y.

J Laryngol Otol. 2008 Feb;122(2):193-8. Epub 2007 Aug 1.

PMID:
17669226
42.

Induction of GDF-15/NAG-1/MIC-1 in human lung carcinoma cells by retinoid-related molecules and assessment of its role in apoptosis.

Kadara H, Schroeder CP, Lotan D, Pisano C, Lotan R.

Cancer Biol Ther. 2006 May;5(5):518-22. Epub 2006 May 13.

PMID:
16582595
43.

Clinical and molecular findings in a family with the carbonic anhydrase II deficiency syndrome.

Lotan D, Eisenkraft A, Jacobsson JM, Bar-Yosef O, Kleta R, Gal N, Raviv-Zilka L, Gore H, Anikster Y.

Pediatr Nephrol. 2006 Mar;21(3):423-6. Epub 2005 Dec 29.

PMID:
16382316
44.

Novel TRPM6 mutations in 21 families with primary hypomagnesemia and secondary hypocalcemia.

Schlingmann KP, Sassen MC, Weber S, Pechmann U, Kusch K, Pelken L, Lotan D, Syrrou M, Prebble JJ, Cole DE, Metzger DL, Rahman S, Tajima T, Shu SG, Waldegger S, Seyberth HW, Konrad M.

J Am Soc Nephrol. 2005 Oct;16(10):3061-9. Epub 2005 Aug 17.

45.

Beta1- or beta2-blockers to improve hemodynamics following endotracheal adrenaline administration.

Ben-Abraham R, Stepensky D, Assoulin-Dayan Y, Efrati O, Lotan D, Manisterski Y, Berkovitch M, Barzilay Z, Paret G.

Drug Metabol Drug Interact. 2005;21(1):31-9.

PMID:
16086554
46.

Enhanced growth inhibition and apoptosis induction in NSCLC cell lines by combination of celecoxib and 4HPR at clinically relevant concentrations.

Sun SY, Schroeder CP, Yue P, Lotan D, Hong WK, Lotan R.

Cancer Biol Ther. 2005 Apr;4(4):407-13. Epub 2005 Apr 21.

PMID:
15846100
47.

Progressive nephropathy associated with mitochondrial tRNA gene mutation.

Dinour D, Mini S, Polak-Charcon S, Lotan D, Holtzman EJ.

Clin Nephrol. 2004 Aug;62(2):149-54.

PMID:
15356973
48.

Hypermethylation of the retinoic acid receptor-beta(2) gene in head and neck carcinogenesis.

Youssef EM, Lotan D, Issa JP, Wakasa K, Fan YH, Mao L, Hassan K, Feng L, Lee JJ, Lippman SM, Hong WK, Lotan R.

Clin Cancer Res. 2004 Mar 1;10(5):1733-42.

49.

Tracheal epinephrine or norepinephrine preceded by beta blockade in a dog model. Can beta blockade bestow any benefits?

Elizur A, Ben-Abraham R, Manisterski Y, Barak A, Efrati O, Lotan D, Barzilay Z, Paret G.

Resuscitation. 2003 Nov;59(2):271-6.

PMID:
14625119
50.

Red blood cell intracellular electrolyte concentration in children with acute hyponatremia.

Ben-Abraham R, Szold O, Menachem S, Lotan D, Steinmetz D, Barzilay Z, Shapira I, Paret G.

J Med. 2002;33(1-4):199-208.

PMID:
12939119

Supplemental Content

Support Center